# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://sam.gov/opp/7b8e625f7406478681bcd5af07ca7f2b/view
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell, adjusts target to $7 from $0.2 (1-40 Rever...
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate ...
Goldman Sachs analyst Matthew Sykes maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target fr...